Structural characterization of the main immunogenic region of the Torpedo acetylcholine receptor

Stuart W. Morell, Vu B. Trinh, Eswari Gudipati, Alexander Friend, Nelson A. Page, Mark A. Agius, David P Richman, Robert H Fairclough

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

To develop antigen-specific immunotherapies for autoimmune diseases, knowledge of the molecular structure of targeted immunological hotspots will guide the production of reagents to inhibit and halt production of antigen specific attack agents. To this end we have identified three noncontiguous segments of the Torpedo nicotinic acetylcholine receptor (AChR) α-subunit that contribute to the conformationally sensitive immunological hotspot on the AChR termed the main immunogenic region (MIR): α(1-12), α(65-79), and α(110-115). This region is the target of greater than 50% of the anti-AChR Abs in serum from patients with myasthenia gravis (MG) and animals with experimental autoimmune myasthenia gravis (EAMG). Many monoclonal antibodies (mAbs) raised in one species against an electric organ AChR cross react with the neuromuscular AChR MIR in several species. Probing the Torpedo AChR α-subunit with mAb 132A, a disease inducing anti-MIR mAb raised against the Torpedo AChR, we have determined that two of the three MIR segments, α(1-12) and α(65-79), form a complex providing the signature components recognized by mAb 132A. These two segments straddle a third, α(110-115), that seems not to contribute specific side chains for 132A recognition, but is necessary for optimum antibody binding. This third segment appears to form a foundation upon which the three-dimensional 132A epitope is anchored.

Original languageEnglish (US)
Pages (from-to)116-131
Number of pages16
JournalMolecular Immunology
Volume58
Issue number1
DOIs
StatePublished - Mar 2014

Fingerprint

Torpedo
Cholinergic Receptors
Autoimmune Experimental Myasthenia Gravis
Electric Organ
Antigens
Myasthenia Gravis
Nicotinic Receptors
Molecular Structure
Immunotherapy
Autoimmune Diseases
Epitopes
Monoclonal Antibodies
Antibodies
Serum

Keywords

  • AChR main immunogenic region (MIR)
  • Anti-MIR monoclonal antibody
  • Conformational epitope structure
  • EAMG
  • Fusion peptide screening
  • MG
  • Pathogenic Abs
  • Site-specific mutagenesis
  • Western blots

ASJC Scopus subject areas

  • Molecular Biology
  • Immunology

Cite this

Structural characterization of the main immunogenic region of the Torpedo acetylcholine receptor. / Morell, Stuart W.; Trinh, Vu B.; Gudipati, Eswari; Friend, Alexander; Page, Nelson A.; Agius, Mark A.; Richman, David P; Fairclough, Robert H.

In: Molecular Immunology, Vol. 58, No. 1, 03.2014, p. 116-131.

Research output: Contribution to journalArticle

Morell, Stuart W. ; Trinh, Vu B. ; Gudipati, Eswari ; Friend, Alexander ; Page, Nelson A. ; Agius, Mark A. ; Richman, David P ; Fairclough, Robert H. / Structural characterization of the main immunogenic region of the Torpedo acetylcholine receptor. In: Molecular Immunology. 2014 ; Vol. 58, No. 1. pp. 116-131.
@article{22853fcf3022438e908fb7a1018756ef,
title = "Structural characterization of the main immunogenic region of the Torpedo acetylcholine receptor",
abstract = "To develop antigen-specific immunotherapies for autoimmune diseases, knowledge of the molecular structure of targeted immunological hotspots will guide the production of reagents to inhibit and halt production of antigen specific attack agents. To this end we have identified three noncontiguous segments of the Torpedo nicotinic acetylcholine receptor (AChR) α-subunit that contribute to the conformationally sensitive immunological hotspot on the AChR termed the main immunogenic region (MIR): α(1-12), α(65-79), and α(110-115). This region is the target of greater than 50{\%} of the anti-AChR Abs in serum from patients with myasthenia gravis (MG) and animals with experimental autoimmune myasthenia gravis (EAMG). Many monoclonal antibodies (mAbs) raised in one species against an electric organ AChR cross react with the neuromuscular AChR MIR in several species. Probing the Torpedo AChR α-subunit with mAb 132A, a disease inducing anti-MIR mAb raised against the Torpedo AChR, we have determined that two of the three MIR segments, α(1-12) and α(65-79), form a complex providing the signature components recognized by mAb 132A. These two segments straddle a third, α(110-115), that seems not to contribute specific side chains for 132A recognition, but is necessary for optimum antibody binding. This third segment appears to form a foundation upon which the three-dimensional 132A epitope is anchored.",
keywords = "AChR main immunogenic region (MIR), Anti-MIR monoclonal antibody, Conformational epitope structure, EAMG, Fusion peptide screening, MG, Pathogenic Abs, Site-specific mutagenesis, Western blots",
author = "Morell, {Stuart W.} and Trinh, {Vu B.} and Eswari Gudipati and Alexander Friend and Page, {Nelson A.} and Agius, {Mark A.} and Richman, {David P} and Fairclough, {Robert H}",
year = "2014",
month = "3",
doi = "10.1016/j.molimm.2013.11.005",
language = "English (US)",
volume = "58",
pages = "116--131",
journal = "Molecular Immunology",
issn = "0161-5890",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Structural characterization of the main immunogenic region of the Torpedo acetylcholine receptor

AU - Morell, Stuart W.

AU - Trinh, Vu B.

AU - Gudipati, Eswari

AU - Friend, Alexander

AU - Page, Nelson A.

AU - Agius, Mark A.

AU - Richman, David P

AU - Fairclough, Robert H

PY - 2014/3

Y1 - 2014/3

N2 - To develop antigen-specific immunotherapies for autoimmune diseases, knowledge of the molecular structure of targeted immunological hotspots will guide the production of reagents to inhibit and halt production of antigen specific attack agents. To this end we have identified three noncontiguous segments of the Torpedo nicotinic acetylcholine receptor (AChR) α-subunit that contribute to the conformationally sensitive immunological hotspot on the AChR termed the main immunogenic region (MIR): α(1-12), α(65-79), and α(110-115). This region is the target of greater than 50% of the anti-AChR Abs in serum from patients with myasthenia gravis (MG) and animals with experimental autoimmune myasthenia gravis (EAMG). Many monoclonal antibodies (mAbs) raised in one species against an electric organ AChR cross react with the neuromuscular AChR MIR in several species. Probing the Torpedo AChR α-subunit with mAb 132A, a disease inducing anti-MIR mAb raised against the Torpedo AChR, we have determined that two of the three MIR segments, α(1-12) and α(65-79), form a complex providing the signature components recognized by mAb 132A. These two segments straddle a third, α(110-115), that seems not to contribute specific side chains for 132A recognition, but is necessary for optimum antibody binding. This third segment appears to form a foundation upon which the three-dimensional 132A epitope is anchored.

AB - To develop antigen-specific immunotherapies for autoimmune diseases, knowledge of the molecular structure of targeted immunological hotspots will guide the production of reagents to inhibit and halt production of antigen specific attack agents. To this end we have identified three noncontiguous segments of the Torpedo nicotinic acetylcholine receptor (AChR) α-subunit that contribute to the conformationally sensitive immunological hotspot on the AChR termed the main immunogenic region (MIR): α(1-12), α(65-79), and α(110-115). This region is the target of greater than 50% of the anti-AChR Abs in serum from patients with myasthenia gravis (MG) and animals with experimental autoimmune myasthenia gravis (EAMG). Many monoclonal antibodies (mAbs) raised in one species against an electric organ AChR cross react with the neuromuscular AChR MIR in several species. Probing the Torpedo AChR α-subunit with mAb 132A, a disease inducing anti-MIR mAb raised against the Torpedo AChR, we have determined that two of the three MIR segments, α(1-12) and α(65-79), form a complex providing the signature components recognized by mAb 132A. These two segments straddle a third, α(110-115), that seems not to contribute specific side chains for 132A recognition, but is necessary for optimum antibody binding. This third segment appears to form a foundation upon which the three-dimensional 132A epitope is anchored.

KW - AChR main immunogenic region (MIR)

KW - Anti-MIR monoclonal antibody

KW - Conformational epitope structure

KW - EAMG

KW - Fusion peptide screening

KW - MG

KW - Pathogenic Abs

KW - Site-specific mutagenesis

KW - Western blots

UR - http://www.scopus.com/inward/record.url?scp=84890076948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890076948&partnerID=8YFLogxK

U2 - 10.1016/j.molimm.2013.11.005

DO - 10.1016/j.molimm.2013.11.005

M3 - Article

VL - 58

SP - 116

EP - 131

JO - Molecular Immunology

JF - Molecular Immunology

SN - 0161-5890

IS - 1

ER -